Lessons

    1. Risk stratification for patients with intermediate risk bladder cancer

    2. Quality of life, counseling, and treatment strategies for bladder cancer patients

    3. Patient preparation and in-office procedures for low-grade tumors

    4. Criteria for in-office fulguration, recurrence timelines, and patient resources for bladder cancer

    5. Patient-centered treatment options and research for intermediate risk NMIBC

    1. Definitions, patient care strategies, and treatment options for intermediate risk bladder cancer

    2. Patient management challenges and new FDA-approved agents for bladder cancer

    3. Delivery methods in bladder cancer treatments, focusing on quality of life

    4. Cost-effective therapeutic approaches to NMIBC

    5. Improving intermediate risk disease outcomes through guidelines, biomarkers, and patient counseling

    1. The Challenge of BCG Shortages in Bladder Cancer Treatment

    2. Strategies For Managing BCG Shortages In Bladder Cancer Therapy

    3. New Therapies For Intermediate Risk Patients Beyond Traditional BCG Treatments

    4. Analyzing Bladder Cancer Treatments, Efficacy Of Gemcitabine, Docetaxel, And TAR-200

    5. New Treatments Options For BCG Refractory Bladder Cancer

    6. BCG Alternatives, Patient Quality Of Life, And Future Guidelines

    7. Supply Chain Resilience And BCG Allocation Strategies Amid Shortages

About this course

  • Free
  • 17 lessons
  • 1.5 hours of video content